Abstract
ABSTRACT
 Objective: The aim of this study is to investigate the effect of the preemptive use of plerixafor in patients with lymphoma and multiple
 myeloma which was administered as a preemptive single dose to the patients who were determined to have a CD34+ cell count of
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
